Vincent Galullo

The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase

Keith P. Wilson, Patricia G. McCaffrey, Kathy Hsiao et al. · Chemistry & Biology · 1997 · 275 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase

Ted Fox, Joyce T. Coll, Xiaoling Xie et al. · Protein Science · 1998 · 135 citations

Life Sciences, Molecular Biology, Pharmacology +13

Cellular and biochemical characterization of VX-710 as a chemosensitizer

Ursula A. Germann, Dlna Shlyakhter, Valerie S. Mason et al. · Anti-Cancer Drugs · 1997 · 130 citations

Medicine, Oncology, Pharmacology +14

Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases

Gregory S. Basarab, Günther Kern, John McNulty et al. · Scientific Reports · 2015 · 104 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II: Broad-Spectrum Antibacterial Agents with Reduced hERG Activity

Folkert Reck, Richard A. Alm, Patrick Brassil et al. · Journal of Medicinal Chemistry · 2011 · 103 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17